Cargando…

Alterations in metabolic flux in migraine and the translational relevance

BACKGROUND: Migraine is a highly prevalent disorder with significant economical and personal burden. Despite the development of effective therapeutics, the causes which precipitate migraine attacks remain elusive. Clinical studies have highlighted altered metabolic flux and mitochondrial function in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grech, Olivia, Sassani, Matilde, Terwindt, Gisela, Lavery, Gareth G., Mollan, Susan P., Sinclair, Alexandra J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523955/ https://www.ncbi.nlm.nih.gov/pubmed/36175833 http://dx.doi.org/10.1186/s10194-022-01494-w

Ejemplares similares

The Role of Metabolism in Migraine Pathophysiology and Susceptibility
por: Grech, Olivia, et al.
Publicado: (2021)

Emerging themes in idiopathic intracranial hypertension
por: Grech, Olivia, et al.
Publicado: (2020)

Longitudinal prospective cohort study evaluating prognosis in idiopathic intracranial hypertension patients with and without comorbid polycystic ovarian syndrome
por: Thaller, Mark, et al.
Publicado: (2023)

Dysregulation of Amino Acid, Lipid, and Acylpyruvate Metabolism in Idiopathic Intracranial Hypertension: A Non-targeted Case Control and Longitudinal Metabolomic Study
por: Alimajstorovic, Zerin, et al.
Publicado: (2022)

Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure
por: Grech, Olivia, et al.
Publicado: (2021)

Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension
por: Yiangou, Andreas, et al.
Publicado: (2020)

Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation
por: Yiangou, Andreas, et al.
Publicado: (2020)

Nuclear Magnetic Resonance Spectroscopy Metabolomics in Idiopathic Intracranial Hypertension to Identify Markers of Disease and Headache
por: Grech, Olivia, et al.
Publicado: (2022)

Evaluation of diurnal and postural intracranial pressure employing telemetric monitoring in idiopathic intracranial hypertension
por: Mitchell, James L, et al.
Publicado: (2022)

Current Perspective on Retinal Migraine
por: Chong, Yu Jeat, et al.
Publicado: (2021)

Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension
por: Westgate, Connar S.J., et al.
Publicado: (2021)

Advance in genetics of migraine
por: de Boer, Irene, et al.
Publicado: (2019)

Current Perspectives on Idiopathic Intracranial Hypertension without Papilloedema
por: Mollan, Susan P., et al.
Publicado: (2021)

Genetics of migraine aura: an update
por: de Boer, Irene, et al.
Publicado: (2020)

Migraine, cerebrovascular disease and the metabolic syndrome
por: Sinclair, Alexandra J., et al.
Publicado: (2012)

A Neuro-Ophthalmologist’s Guide to Advances in Intracranial Pressure Measurements
por: Mollan, Susan P, et al.
Publicado: (2023)

The potential danger of blocking CGRP for treating migraine in CADASIL patients
por: de Boer, Irene, et al.
Publicado: (2020)

Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine
por: Pijpers, Judith A, et al.
Publicado: (2020)

Linking migraine frequency with family history of migraine
por: Pelzer, Nadine, et al.
Publicado: (2018)

Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My‐LIFE European Delphi survey
por: Pozo‐Rosich, Patricia, et al.
Publicado: (2021)

Brain atrophy following hemiplegic migraine attacks
por: Pelzer, Nadine, et al.
Publicado: (2017)

Premonitory symptoms in glyceryl trinitrate triggered migraine attacks: a case-control study
por: Onderwater, Gerrit L.J., et al.
Publicado: (2020)

Effect of lockdown during COVID-19 on migraine: A longitudinal cohort study
por: Verhagen, Iris E, et al.
Publicado: (2021)

Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
por: Bangs, Mark E., et al.
Publicado: (2020)

Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension
por: Westgate, Connar S J, et al.
Publicado: (2022)

Pain perception in women with menstrually-related migraine
por: Linstra, Katie M, et al.
Publicado: (2020)

Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
por: Bangs, Mark E., et al.
Publicado: (2020)

Determining the role of novel metabolic pathways in driving intracranial pressure reduction after weight loss
por: Alimajstorovic, Zerin, et al.
Publicado: (2023)

Metabolic profile changes in serum of migraine patients detected using (1)H-NMR spectroscopy
por: Harder, Aster V. E., et al.
Publicado: (2021)

Jealousy in women with migraine: a cross-sectional case-control study
por: van Casteren, Daphne S., et al.
Publicado: (2020)

Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention
por: Hornby, Catherine, et al.
Publicado: (2018)

Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2018)

Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT)
por: Yiangou, Andreas, et al.
Publicado: (2021)

Debate: Are cluster headache and migraine distinct headache disorders?
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2022)

Large-scale plasma metabolome analysis reveals alterations in HDL metabolism in migraine
por: Onderwater, Gerrit L.J., et al.
Publicado: (2019)

Cutaneous allodynia as predictor for treatment response in chronic migraine: a cohort study
por: Pijpers, Judith A., et al.
Publicado: (2023)

Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process
por: Steiner, Timothy J, et al.
Publicado: (2022)

Serum CGRP in migraine patients using erenumab as preventive treatment
por: de Vries Lentsch, Simone, et al.
Publicado: (2022)

Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension
por: Mollan, S. P., et al.
Publicado: (2021)

Sex differences in prevalence of migraine trigger factors: A cross-sectional study
por: van Casteren, Daphne S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gao1ft6one9jf5vsj4sidkorfa